Page last updated: 2024-12-07

4-nitrososulfamethoxazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-nitrososulfamethoxazole: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

nitrososulfamethoxazole : A sulfonamide compound having a 4-nitrosophenyl group attached to the sulfur atom and a 1,2-oxazol-3-yl group attached to the nitrogen atom. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID125483
CHEMBL ID3827762
CHEBI ID53017
MeSH IDM0197396

Synonyms (26)

Synonym
4-nitrososulfamethoxazole
smx-no
nitrososulfamethoxazole
n-(5-methylisoxazol-3-yl)-4-nitrosobenzenesulfonamide
nitroso sulphamethoxazole
n-(5-methyl-3-isoxazolyl)-4-nitrosobenzenesulfonamide
CHEBI:53017 ,
131549-85-4
C90154
n-(5-methyl-1,2-oxazol-3-yl)-4-nitrosobenzenesulfonamide
4-nitroso sulfamethoxazole, > 90%
FT-0672999
unii-kk4e4d7f9y
benzenesulfonamide, n-(5-methyl-3-isoxazolyl)-4-nitroso-
kk4e4d7f9y ,
EPITOPE ID:115001
4-nitroso sulfamethoxazole
CHEMBL3827762
DTXSID60157105
4-nitrososulfamethoxazole, analytical standard
AKOS030239892
J-006022
4-nitroso-smx
Q27123889
4-nitroso sulfamethoxazole, > 90per cent
n-(5-methyl-1,2-oxazol-3-yl)-4-nitrosobenzene-1-sulfonamide

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dosing was by the intraperitoneal route, once daily for four consecutive days per week, for 2 weeks total, followed by a third week of observation."( Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study.
Lavergne, SN; Maki, JE; Trepanier, LA; Volkman, EM; Yoder, AR, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
allergenA chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
isoxazolesOxazoles in which the N and O atoms are adjacent.
sulfonamideAn amide of a sulfonic acid RS(=O)2NR'2.
nitroso compoundCompounds having the nitroso group, -NO, attached to carbon, or to another element, most commonly nitrogen or oxygen.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1313999Stability of the compound2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Modification of existing antibiotics in the form of precursor prodrugs that can be subsequently activated by nitroreductases of the target pathogen.
AID1314011Drug level assessed as Staphylococcus saprophyticus ATCC 15305 nitroreductase B mediated compound formation using 130 uM NO2-SMX measured after 200 mins in presence of NADPH-cofactor generating system by LC-MS/MS analysis2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Modification of existing antibiotics in the form of precursor prodrugs that can be subsequently activated by nitroreductases of the target pathogen.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.40 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (9.09%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]